Cytori to Address Nasdaq Listing via Nasdaq Hearing Panel
Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that it has
received formal confirmation from The Nasdaq Stock Market LLC (“Nasdaq”)
that Cytori’s request for an oral hearing with the Nasdaq Hearing Panel
(“Panel”) has been granted. The hearing will occur on January 21, 2016
at Nasdaq’s Washington, D.C. offices. During the period prior to the
hearing, Cytori’s common stock will continue to trade on The Nasdaq
Global Market (“NGM”). Read more [...]